登录

Linkedcare Gets 200 Million Yuan in Series C2

作者: Mailman 2020-12-04 11:36
领健Linkedcare
http://www.linkedcare.cn/
企业数据由 动脉橙 提供支持
医疗信息化管理系统研发商 | D+轮 | 运营中
中国-上海
2021-12-29
同创伟业
查看

Linkedcare, a Chinese software-as-a-service supply chain platform focusing on dental care and aesthetic medicine, announced that it has closed 200 million yuan (US$30.5 million) in a series C2 round of funding led by Lightspeed China Partners and So-Young International.Existing investor Matrix Partners China also participated in the round.


Founded in 2015, Linkedcare claims that it provides its cloud-based management software and supply chain solutions to over 30,000 dental clinics and aesthetic medicine organizations in China.


It also claims that its ecommerce platform connects over 300 brands and that it owns more than 10,000 stock-keeping units.


Covid-19 has accelerated the digitalization of medical institutions in China, according to Francis Kao, associate partner at Lightspeed China Partners. By 2020, the country’s healthcare market is expected to hit US$1 trillion, growing at a compound annual growth rate of 12% from US$357 billion in 2011.


With the new funds, Linkedcare will invest in the research and development of the digitalization and intellectualization of its dental management software and aesthetic medicine software. It will also build nine more regional warehouses and form its sales team.

The latest investment comes after the Shanghai-based company secured 100 million yuan (roughly US$15.2 million) in a series C1 round led by Taikang Asset Management and Everest VC in 2019. Additional investors include Meituan Dianping and Fosun Pharmaceutical, among others.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

【首发】迪英加再获近亿元B1轮投资,计划在明年年底覆盖全国1000家医院

2020-12-04
下一篇

NVIDIA GPU助力燧坤智能新药研发,提速药物筛选流程数十倍

2020-12-04